drugset / Trial / NCT01603355
Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
NaSingle-groupOpen-labelTreatment
Summary
The investigators are doing this research study to see if tocilizumab (Actemra) is safe and effective when used for severe or refractory non-infectious uveitis. Uveitis is an inflammation of the eye that is caused by the body's immune system reacting against the eye tissues.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocilizumab | Monoclonal antibody | 8 mg/kg | Intravenous |
| Subject | Tocilizumab | Monoclonal antibody | 10 mg/kg | Intravenous |